Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Envi™-SR Randomized Controlled Trial for Endovascular Treatment of Ischemic Stroke

NCT: NCT05107206 · TERMINATED

NCT IDNCT05107206
StatusTERMINATED
Start Date2022-06-23
Completion2025-01-27

Brief Summary

The study objective is to examine and compare clinical outcomes, as measured by Modified Rankin Scale (mRS) at 90 days (± 15 days) post treatment, and related performance characteristics of the Envi™-SR and concurrent parallel Control Devices currently cleared by the U.S. FDA for treatment of stroke.

Frequently Asked Questions

What is Envi™-SR Randomized Controlled Trial for Endovascular Treatment of Ischemic Stroke?

Envi™-SR Randomized Controlled Trial for Endovascular Treatment of Ischemic Stroke is a clinical trial registered under NCT05107206. Current status: TERMINATED.

What is the status of NCT05107206?

The current status of NCT05107206 (Envi™-SR Randomized Controlled Trial for Endovascular Treatment of Ischemic Stroke) is: TERMINATED.

When did Envi™-SR Randomized Controlled Trial for Endovascular Treatment of Ischemic Stroke start?

Envi™-SR Randomized Controlled Trial for Endovascular Treatment of Ischemic Stroke started on 2022-06-23.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑